Pirfenidone exerts beneficial effects in patients with IPF undergoing single lung transplantation

An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management

Ganesh Raghu, Harold R. Collard, Jim Egan et al. · American Journal of Respiratory and Critical Care Medicine · 2011 · 7.3K citations · Full text

Medicine, Clinical Sciences, Internal Medicine +17

A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis

Talmadge E. King, Williamson Z. Bradford, Socorro Castro-Bernardini et al. · New England Journal of Medicine · 2014 · 3.9K citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +13

Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials

Paul W. Noble, Carlo Albera, Williamson Z. Bradford et al. · The Lancet · 2011 · 2.1K citations

Medicine, Clinical Sciences, Pharmacotherapy +8

Double-blind, Placebo-controlled Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis

Arata Azuma, Toshihiro Nukiwa, Eiyasu Tsuboi et al. · American Journal of Respiratory and Critical Care Medicine · 2005 · 954 citations

Medicine, Pharmacotherapy, Exercise Testing +15

Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: Lung Rejection Study Group.

Samuel A. Yousem, Gerald J. Berry, Philip T. Cagle et al. · PubMed · 1996 · 847 citations

Life Sciences, Immunology, Pulmonology +11